RSS Feeds
Cholesterol and Violence: Is There A Connection?
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Dr. Golomb's article on the possible relation between cholesterol levels and violent behavior [1] raises important issues on how our interventions to improve health can unwittingly cause harm. The article did inspire me to comment on how, I believe, some in our medical and pharmaceutical community might view these concerns. Not all problems present an opportunity.
“Cholesterol and serotonin are the latest debate
How lowering the former will inevitably relate
To lowering the latter and in such a state
The heart will be healthy, the mind full of hate.
Cholesterol, cholesterol, you've been such a scourge,
Lower, lower levels, the doctors all urged
From your diets the saturated fats you must purge
While murder and suicide continue to surge.
Makes sense, doesn't it, when of good food we deprive
Our patients, who for a hamburger and fries,
Would gladly give up the extra minutes they'd survive,
And the rage, into which our nagging can drive.
Opportunity, opportunity, just think of it all,
How McDonald's and Burger King can take up the call,
How something so simple as a burger and fry,
Can satisfy your tastebuds and keep you high.
Pharmaceutical companies can afford to be smug
As they marvel at the market for a new combo drug.
Lower cholesterol and rage for them opens a door,
Coming soon, the new panacea, Prozacor.”
Richard F. Weinberger, MD
Case Western Reserve University School of Medicine; Cleveland, OH 44106
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright ©2004 by the American College of Physicians
